世界の急性興奮＆攻撃性用医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Agitation and Aggression Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5562 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、急性興奮＆攻撃性用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、筋肉内注射、その他）、用途別市場規模（病院＆外来手術室、精神科医療施設、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・急性興奮＆攻撃性用医薬品の市場動向 ・企業の競争状況、市場シェア ・急性興奮＆攻撃性用医薬品の種類別市場規模と予測2016-2027（経口、筋肉内注射、その他） ・急性興奮＆攻撃性用医薬品の用途別市場規模と予測2016-2027（病院＆外来手術室、精神科医療施設、その他） ・急性興奮＆攻撃性用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・急性興奮＆攻撃性用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性興奮＆攻撃性用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性興奮＆攻撃性用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性興奮＆攻撃性用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Pfizer、Ono Pharmaceutical、Otsuka Holdings、GlaxoSmithKline、Bristol-Myers Squibb、Johnson & Johnson、H. Lundbeck A/S） ・結論

With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas.

Market Analysis and Insights: Global Acute Agitation and Aggression Drugs Market
The global Acute Agitation and Aggression Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Agitation and Aggression Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Agitation and Aggression Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Agitation and Aggression Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Agitation and Aggression Drugs market.

Global Acute Agitation and Aggression Drugs Scope and Market Size
Acute Agitation and Aggression Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Agitation and Aggression Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Intramuscular Injection
Others

Segment by Application
Hospitals & Ambulatory Surgical Centers
Psychiatric Care Facilities
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly and Company
Pfizer
Ono Pharmaceutical
Otsuka Holdings
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
H. Lundbeck A/S

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Intramuscular Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Agitation and Aggression Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Ambulatory Surgical Centers
1.3.3 Psychiatric Care Facilities
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Agitation and Aggression Drugs Market Perspective (2016-2027)
2.2 Acute Agitation and Aggression Drugs Growth Trends by Regions
2.2.1 Acute Agitation and Aggression Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Agitation and Aggression Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Acute Agitation and Aggression Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Acute Agitation and Aggression Drugs Industry Dynamic
2.3.1 Acute Agitation and Aggression Drugs Market Trends
2.3.2 Acute Agitation and Aggression Drugs Market Drivers
2.3.3 Acute Agitation and Aggression Drugs Market Challenges
2.3.4 Acute Agitation and Aggression Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Agitation and Aggression Drugs Players by Revenue
3.1.1 Global Top Acute Agitation and Aggression Drugs Players by Revenue (2016-2021)
3.1.2 Global Acute Agitation and Aggression Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Acute Agitation and Aggression Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Agitation and Aggression Drugs Revenue
3.4 Global Acute Agitation and Aggression Drugs Market Concentration Ratio
3.4.1 Global Acute Agitation and Aggression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Drugs Revenue in 2020
3.5 Acute Agitation and Aggression Drugs Key Players Head office and Area Served
3.6 Key Players Acute Agitation and Aggression Drugs Product Solution and Service
3.7 Date of Enter into Acute Agitation and Aggression Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Agitation and Aggression Drugs Breakdown Data by Type
4.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Type (2016-2021)
4.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2022-2027)

5 Acute Agitation and Aggression Drugs Breakdown Data by Application
5.1 Global Acute Agitation and Aggression Drugs Historic Market Size by Application (2016-2021)
5.2 Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Agitation and Aggression Drugs Market Size (2016-2027)
6.2 North America Acute Agitation and Aggression Drugs Market Size by Type
6.2.1 North America Acute Agitation and Aggression Drugs Market Size by Type (2016-2021)
6.2.2 North America Acute Agitation and Aggression Drugs Market Size by Type (2022-2027)
6.2.3 North America Acute Agitation and Aggression Drugs Market Size by Type (2016-2027)
6.3 North America Acute Agitation and Aggression Drugs Market Size by Application
6.3.1 North America Acute Agitation and Aggression Drugs Market Size by Application (2016-2021)
6.3.2 North America Acute Agitation and Aggression Drugs Market Size by Application (2022-2027)
6.3.3 North America Acute Agitation and Aggression Drugs Market Size by Application (2016-2027)
6.4 North America Acute Agitation and Aggression Drugs Market Size by Country
6.4.1 North America Acute Agitation and Aggression Drugs Market Size by Country (2016-2021)
6.4.2 North America Acute Agitation and Aggression Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Agitation and Aggression Drugs Market Size (2016-2027)
7.2 Europe Acute Agitation and Aggression Drugs Market Size by Type
7.2.1 Europe Acute Agitation and Aggression Drugs Market Size by Type (2016-2021)
7.2.2 Europe Acute Agitation and Aggression Drugs Market Size by Type (2022-2027)
7.2.3 Europe Acute Agitation and Aggression Drugs Market Size by Type (2016-2027)
7.3 Europe Acute Agitation and Aggression Drugs Market Size by Application
7.3.1 Europe Acute Agitation and Aggression Drugs Market Size by Application (2016-2021)
7.3.2 Europe Acute Agitation and Aggression Drugs Market Size by Application (2022-2027)
7.3.3 Europe Acute Agitation and Aggression Drugs Market Size by Application (2016-2027)
7.4 Europe Acute Agitation and Aggression Drugs Market Size by Country
7.4.1 Europe Acute Agitation and Aggression Drugs Market Size by Country (2016-2021)
7.4.2 Europe Acute Agitation and Aggression Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Agitation and Aggression Drugs Market Size (2016-2027)
8.2 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type
8.2.1 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application
8.3.1 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region
8.4.1 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Agitation and Aggression Drugs Market Size (2016-2027)
9.2 Latin America Acute Agitation and Aggression Drugs Market Size by Type
9.2.1 Latin America Acute Agitation and Aggression Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Acute Agitation and Aggression Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Acute Agitation and Aggression Drugs Market Size by Type (2016-2027)
9.3 Latin America Acute Agitation and Aggression Drugs Market Size by Application
9.3.1 Latin America Acute Agitation and Aggression Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Acute Agitation and Aggression Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Acute Agitation and Aggression Drugs Market Size by Application (2016-2027)
9.4 Latin America Acute Agitation and Aggression Drugs Market Size by Country
9.4.1 Latin America Acute Agitation and Aggression Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Acute Agitation and Aggression Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Agitation and Aggression Drugs Market Size (2016-2027)
10.2 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type
10.2.1 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application
10.3.1 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country
10.4.1 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Acute Agitation and Aggression Drugs Introduction
11.2.4 Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Ono Pharmaceutical
11.3.1 Ono Pharmaceutical Company Details
11.3.2 Ono Pharmaceutical Business Overview
11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Introduction
11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.3.5 Ono Pharmaceutical Recent Development
11.4 Otsuka Holdings
11.4.1 Otsuka Holdings Company Details
11.4.2 Otsuka Holdings Business Overview
11.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Introduction
11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.4.5 Otsuka Holdings Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Acute Agitation and Aggression Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 H. Lundbeck A/S
11.8.1 H. Lundbeck A/S Company Details
11.8.2 H. Lundbeck A/S Business Overview
11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Introduction
11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2016-2021)
11.8.5 H. Lundbeck A/S Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Intramuscular Injection
Table 4. Key Players of Others
Table 5. Global Acute Agitation and Aggression Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Agitation and Aggression Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Agitation and Aggression Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Agitation and Aggression Drugs Market Share by Regions (2016-2021)
Table 9. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Agitation and Aggression Drugs Market Share by Regions (2022-2027)
Table 11. Acute Agitation and Aggression Drugs Market Trends
Table 12. Acute Agitation and Aggression Drugs Market Drivers
Table 13. Acute Agitation and Aggression Drugs Market Challenges
Table 14. Acute Agitation and Aggression Drugs Market Restraints
Table 15. Global Acute Agitation and Aggression Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Agitation and Aggression Drugs Market Share by Players (2016-2021)
Table 17. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Drugs as of 2020)
Table 18. Ranking of Global Top Acute Agitation and Aggression Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Agitation and Aggression Drugs Product Solution and Service
Table 22. Date of Enter into Acute Agitation and Aggression Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Agitation and Aggression Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Agitation and Aggression Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Agitation and Aggression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Agitation and Aggression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Agitation and Aggression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Agitation and Aggression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Agitation and Aggression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Agitation and Aggression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Agitation and Aggression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Agitation and Aggression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Agitation and Aggression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Agitation and Aggression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Agitation and Aggression Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Agitation and Aggression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Agitation and Aggression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Agitation and Aggression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Agitation and Aggression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Agitation and Aggression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly and Company Company Details
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Acute Agitation and Aggression Drugs Product
Table 65. Eli Lilly and Company Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Acute Agitation and Aggression Drugs Product
Table 70. Pfizer Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Ono Pharmaceutical Company Details
Table 73. Ono Pharmaceutical Business Overview
Table 74. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product
Table 75. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 76. Ono Pharmaceutical Recent Development
Table 77. Otsuka Holdings Company Details
Table 78. Otsuka Holdings Business Overview
Table 79. Otsuka Holdings Acute Agitation and Aggression Drugs Product
Table 80. Otsuka Holdings Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 81. Otsuka Holdings Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Acute Agitation and Aggression Drugs Product
Table 85. GlaxoSmithKline Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product
Table 90. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Acute Agitation and Aggression Drugs Product
Table 95. Johnson & Johnson Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. H. Lundbeck A/S Company Details
Table 98. H. Lundbeck A/S Business Overview
Table 99. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Drugs Business (2016-2021) & (US$ Million)
Table 100. H. Lundbeck A/S Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Agitation and Aggression Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Intramuscular Injection Features
Figure 4. Others Features
Figure 5. Global Acute Agitation and Aggression Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 7. Psychiatric Care Facilities Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Agitation and Aggression Drugs Report Years Considered
Figure 10. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Agitation and Aggression Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Agitation and Aggression Drugs Market Share by Regions (2022-2027)
Figure 14. Global Acute Agitation and Aggression Drugs Market Share by Players in 2020
Figure 15. Global Top Acute Agitation and Aggression Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Drugs Revenue in 2020
Figure 17. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Agitation and Aggression Drugs Market Share by Type (2016-2027)
Figure 21. North America Acute Agitation and Aggression Drugs Market Share by Application (2016-2027)
Figure 22. North America Acute Agitation and Aggression Drugs Market Share by Country (2016-2027)
Figure 23. United States Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Agitation and Aggression Drugs Market Share by Type (2016-2027)
Figure 27. Europe Acute Agitation and Aggression Drugs Market Share by Application (2016-2027)
Figure 28. Europe Acute Agitation and Aggression Drugs Market Share by Country (2016-2027)
Figure 29. Germany Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Agitation and Aggression Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Agitation and Aggression Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Agitation and Aggression Drugs Market Share by Region (2016-2027)
Figure 39. China Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Agitation and Aggression Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Acute Agitation and Aggression Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Acute Agitation and Aggression Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Agitation and Aggression Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 60. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 61. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 65. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---